Peptide record

TPDB09709

Antibacterial Cell-penetrating Peptides Hemolysis Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09709
Antibacterial Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia CPPsite3.0 PD_Hemolysis
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Cell-penetrating Peptides, Hemolysis, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KIAGKIAKIAGKIAKIAGKIA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C96H179N27O22
RNDCEQHLMFPSTWYV
AIK
2063.64
11.21
6
0
12
+6
-0.47
0.629
140.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
6
A
0
R
0
N
0
D
0
C
0
E
0
Q
3
G
0
H
6
I
0
L
6
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 6 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 6 L: 0 K: 6 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
21 reviewed residue count
C96H179N27O22 sequence-only estimate (linear, free termini)
2063.64 sequence-only estimate (linear, free termini)
11.21 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
-0.47 sequence-only estimate (linear, free termini)
0.629 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

6% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
6% Hemolysis | 32 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides | Pure Appl Chem | 2007
Evidence 2 Activity

Activity

8% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
8% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides | Pure Appl Chem | 2007
Evidence 3 Activity

Activity

14% Hemolysis
Toxicity
512 µg/mL
Hemolytic Cytotoxic
14% Hemolysis | 512 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides | Pure Appl Chem | 2007
Evidence 4 Activity

Activity

19% Hemolysis
Toxicity
1024 µg/mL
Hemolytic Cytotoxic
19% Hemolysis | 1024 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides | Pure Appl Chem | 2007
Evidence 5 Activity

Activity

9% Hemolysis
Toxicity
500 µg/mL
Hemolytic Cytotoxic
9% Hemolysis | 500 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids | J Biol Chem | 2001
Evidence 6 Activity

Activity

3% Hemolysis
Toxicity
8 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 8 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells. | Sci Rep | 2015
Evidence 7 Activity

Activity

7% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
7% Hemolysis | 32 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells. | Sci Rep | 2015
Evidence 8 Activity

Activity

15% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
15% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells. | Sci Rep | 2015
Evidence 9 Activity

Activity

38% Hemolysis
Toxicity
512 µg/mL
Hemolytic Cytotoxic
38% Hemolysis | 512 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells. | Sci Rep | 2015
Evidence 10 Activity

Activity

51% Hemolysis
Toxicity
1024 µg/mL
Hemolytic Cytotoxic
51% Hemolysis | 1024 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides | Pure Appl Chem | 2007
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
42 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 42 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Terminal Charges Modulate the Pore Forming Activity of Cationic Amphipathic Helices. | Biochim Biophys Acta | 2020
Evidence 12 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis